Developer docs
API playgroundTry for free, no card

Search company profiles

9R PHARMACEUTICALS

Full company profile

uuid003t54d

Namestring
9R PHARMACEUTICALS
Company typeenum
Private
Founded yearstring
-
Short descriptiontext

9R Pharmaceuticals is a small pharmaceutical company founded in 2018 with approximately 12 employees. Specific therapeutic focus areas, product pipeline, business model, and commercial activities cannot be determined from available sources.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
Markets served

Serves global market

Keyword5 values
pharmaceutical products, drug manufacturing, generic medicines, pharmaceutical formulations, healthcare supplies
Industry1 code
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceuticals
Social media profiles1 record
Cost components3 values
Personnel, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

9R PHARMACEUTICALS is a pharmaceutical company founded in 2018. Based on the limited available information from the company website, it operates in the pharmaceutical sector with a small team of approximately 12 employees. The specific product lines, therapeutic areas, and detailed business activities are not disclosed in the available source material.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Pharmaceutical Products
CategoryPharmaceuticals
No data
Peers10 records
TypeEmerging player
Description

PharmaBlock is a publicly-traded specialty CDMO focused on building blocks, intermediates, and small-molecule API development. Comparable as a smaller, specialty-focused pharma services peer if 9R operates in development or specialty manufacturing.

TypeDirect peer
Description

Novasep is a privately-held CDMO providing API synthesis, chromatography, and specialty manufacturing services. Comparable as a private pharma services peer with overlapping capabilities in process development and small-molecule manufacturing.

TypeDirect peer
Description

Seqens is a privately-held CDMO offering API development, custom synthesis, and specialty manufacturing. Comparable as a mid-sized, privately-held pharma services peer with overlapping scope in small-molecule development and manufacturing.

TypeBroad incumbent
Description

Aenova is a privately-held CDMO providing formulation development, manufacturing, and packaging for oral, topical, and sterile dosage forms. Comparable as a broad incumbent offering overlapping pharma services.

TypeDirect peer
Description

Hovione is a privately-held CDMO specializing in small-molecule API development, particle engineering, and contract manufacturing. Comparable as a privately-held specialty pharma services peer with similar lean operational profile.

TypeDirect peer
Description

Alcami is a privately-held CDMO offering small-molecule API development, manufacturing, and analytical services. Comparable as a similarly-sized, privately-held pharma services peer if 9R operates in development or manufacturing services.

TypeBroad incumbent
Description

PCI Pharma Services is a large private CDMO providing sterile fill-finish, manufacturing, and packaging services. Comparable as a broader incumbent offering overlapping pharma services, though at significantly greater scale than 9R.

TypeOthers
Description

Eurofins Discovery Services offers contract research and laboratory services to the pharmaceutical industry. Comparable as an enabling, thematically-related services peer if 9R operates in pharma testing or development services.

TypeBroad incumbent
Description

Curia is a privately-held CDMO offering API development, drug product manufacturing, and laboratory services. Comparable as a broad incumbent offering overlapping pharma development and manufacturing capabilities.

TypeBroad incumbent
Description

Cambrex is a privately-held CDMO providing small-molecule API development and manufacturing across the full drug lifecycle. Comparable as a broad incumbent offering overlapping pharma services, though at significantly greater scale than 9R.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

9R PHARMACEUTICALS

Pharmaceuticals9rpharmaceuticals.com

9R Pharmaceuticals is a small pharmaceutical company founded in 2018 with approximately 12 employees. Specific therapeutic focus areas, product pipeline, business model, and commercial activities cannot be determined from available sources.

9R PHARMACEUTICALS firmographics

Firmographics
Name
9R PHARMACEUTICALS
Website
https://9rpharmaceuticals.com
Company type
Private
Headcount range
11–50 employees
Short description
9R Pharmaceuticals is a small pharmaceutical company founded in 2018 with approximately 12 employees. Specific therapeutic focus areas, product pipeline, business model, and commercial activities cannot be determined from available sources.
Ownership category
akta.pro rank

9R PHARMACEUTICALS industry classification

Industry
Product category
Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical products
  • Drug manufacturing
  • Generic medicines
  • Pharmaceutical formulations
  • Healthcare supplies

9R PHARMACEUTICALS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain

9R PHARMACEUTICALS product offering

Product offering

Core offering

9R PHARMACEUTICALS is a pharmaceutical company founded in 2018. Based on the limited available information from the company website, it operates in the pharmaceutical sector with a small team of approximately 12 employees. The specific product lines, therapeutic areas, and detailed business activities are not disclosed in the available source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Products

Companies that use 9R PHARMACEUTICALS

Customer profile

Ideal customer profiles1 record

9R PHARMACEUTICALS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

9R PHARMACEUTICALS competitors and assessment

Company assessment

Emerging players

  • PharmaBlock Sciences: PharmaBlock is a publicly-traded specialty CDMO focused on building blocks, intermediates, and small-molecule API development. Comparable as a smaller, specialty-focused pharma services peer if 9R operates in development or specialty manufacturing.

Direct peers

  • Novasep: Novasep is a privately-held CDMO providing API synthesis, chromatography, and specialty manufacturing services. Comparable as a private pharma services peer with overlapping capabilities in process development and small-molecule manufacturing.
  • Seqens: Seqens is a privately-held CDMO offering API development, custom synthesis, and specialty manufacturing. Comparable as a mid-sized, privately-held pharma services peer with overlapping scope in small-molecule development and manufacturing.
  • Hovione: Hovione is a privately-held CDMO specializing in small-molecule API development, particle engineering, and contract manufacturing. Comparable as a privately-held specialty pharma services peer with similar lean operational profile.
  • Alcami Corporation: Alcami is a privately-held CDMO offering small-molecule API development, manufacturing, and analytical services. Comparable as a similarly-sized, privately-held pharma services peer if 9R operates in development or manufacturing services.

Broad incumbents

  • Aenova Group: Aenova is a privately-held CDMO providing formulation development, manufacturing, and packaging for oral, topical, and sterile dosage forms. Comparable as a broad incumbent offering overlapping pharma services.
  • PCI Pharma Services: PCI Pharma Services is a large private CDMO providing sterile fill-finish, manufacturing, and packaging services. Comparable as a broader incumbent offering overlapping pharma services, though at significantly greater scale than 9R.
  • Curia Global (formerly AMRI): Curia is a privately-held CDMO offering API development, drug product manufacturing, and laboratory services. Comparable as a broad incumbent offering overlapping pharma development and manufacturing capabilities.
  • Cambrex: Cambrex is a privately-held CDMO providing small-molecule API development and manufacturing across the full drug lifecycle. Comparable as a broad incumbent offering overlapping pharma services, though at significantly greater scale than 9R.

Others

  • Eurofins Discovery Services: Eurofins Discovery Services offers contract research and laboratory services to the pharmaceutical industry. Comparable as an enabling, thematically-related services peer if 9R operates in pharma testing or development services.

Market position

Strengths2 records

Weaknesses3 records

Key risks6 records

Key highlights2 records

Customer concentration

9R PHARMACEUTICALS social profiles

Digital presence

9R PHARMACEUTICALS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

9R PHARMACEUTICALS leadership team

Management profile

Number of profiles

9R PHARMACEUTICALS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

9R PHARMACEUTICALS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 9R PHARMACEUTICALS

What does 9R PHARMACEUTICALS do?

9R PHARMACEUTICALS is a pharmaceutical company founded in 2018. Based on the limited available information from the company website, it operates in the pharmaceutical sector with a small team of approximately 12 employees. The specific product lines, therapeutic areas, and detailed business activities are not disclosed in the available source material.

When was 9R PHARMACEUTICALS founded?

9R PHARMACEUTICALS was founded in -1. It employs 11 to 50 people.

Who are 9R PHARMACEUTICALS's main competitors?

PharmaBlock Sciences is listed as an emerging player. Direct peers are Novasep, Seqens, Hovione and Alcami Corporation. Broad incumbents are Aenova Group, PCI Pharma Services, Curia Global (formerly AMRI) and Cambrex. Eurofins Discovery Services is listed as an others.

Does 9R PHARMACEUTICALS have an API?

No public API is recorded for 9R PHARMACEUTICALS.

What industry is 9R PHARMACEUTICALS in?

9R PHARMACEUTICALS's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales